DexCom Stock Price, News & Analysis (NASDAQ:DXCM)

$58.45 -3.08 (-5.01 %)
(As of 12/12/2017 04:00 PM ET)
Previous Close$61.53
Today's Range$57.71 - $62.35
52-Week Range$42.62 - $88.80
Volume1.78 million shs
Average Volume1.46 million shs
Market Capitalization$5.35 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.3

About DexCom (NASDAQ:DXCM)

DexCom logoDexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The Company is commercializing its fifth generation CGM system. The Company's markets DexCom G4 PLATINUM under a Conformite Europeenne Marking (CE Mark), in the European Union, Australia, New Zealand and the countries in Asia and Latin America, and in the United States with approval from the United States Food and Drug Administration (FDA). The DexCom G4 PLATINUM with Share remote monitoring system uses a wireless connection between a patient's receiver and an application on the patient's iPhone, iPod touch, or iPad to transmit glucose information to applications on the mobile devices of designated recipients (followers).

Receive DXCM News and Ratings via Email

Sign-up to receive the latest news and ratings for DXCM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:DXCM
CUSIP25213110
Phone858-200-0200

Debt

Debt-to-Equity Ratio0.84%
Current Ratio5.86%
Quick Ratio5.50%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$573.30 million
Price / Sales8.86
Cash FlowN/A
Price / CashN/A
Book Value$3.36 per share
Price / Book17.40

Profitability

Trailing EPS($0.57)
Net Income$-65,600,000.00
Net Margins-7.21%
Return on Equity-20.44%
Return on Assets-10.59%

Miscellaneous

Employees2,300
Outstanding Shares86,900,000

DexCom (NASDAQ:DXCM) Frequently Asked Questions

What is DexCom's stock symbol?

DexCom trades on the NASDAQ under the ticker symbol "DXCM."

How were DexCom's earnings last quarter?

DexCom, Inc. (NASDAQ:DXCM) released its earnings results on Tuesday, August, 2nd. The medical device company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.12) by $0.12. The medical device company had revenue of $137.30 million for the quarter, compared to analysts' expectations of $132.48 million. DexCom had a negative return on equity of 20.44% and a negative net margin of 7.21%. The firm's revenue for the quarter was up 47.3% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.05) EPS. View DexCom's Earnings History.

When will DexCom make its next earnings announcement?

DexCom is scheduled to release their next quarterly earnings announcement on Monday, February, 26th 2018. View Earnings Estimates for DexCom.

Where is DexCom's stock going? Where will DexCom's stock price be in 2017?

20 brokerages have issued twelve-month price objectives for DexCom's shares. Their forecasts range from $49.50 to $95.00. On average, they expect DexCom's share price to reach $71.36 in the next year. View Analyst Ratings for DexCom.

What are Wall Street analysts saying about DexCom stock?

Here are some recent quotes from research analysts about DexCom stock:

  • 1. According to Zacks Investment Research, "Over the past year, DexCom has underperformed the broader industry in terms of price. We believe the company’s margins will continue to be under pressure in the coming quarters, owing to high product development costs and rising expenditures on research & development. Specifically, the company is expected to have lower margins on transmitter sales (in spite of the cost reduction initiatives). Additionally, cutthroat competition in the market for blood & glucose monitoring devices is a major headwind. On the brighter side, the glucose monitoring market represents significant commercial opportunity for DexCom. The company has also signed collaborative agreements with several companies, which should not only bring in cash, but also help expand its product portfolio. In this regard, DexCom's recent collaboration with leading wearables brand – Fitbit, desreves a mention." (10/24/2017)
  • 2. Jefferies Group LLC analysts commented, "DXCM reported 4Q sales $3mn ahead of its pre-announcement. Guidance for 2017 remained +25-30% ($710-740mn); importantly, this considers competitive entries by MDT (670G) and ABT (Libre), but does not factor in any contribution from DXCM patients covered by Medicare. With this low bar set for 2017, the next-gen G6 and the Verily Type 2 system coming in 2018, DXCM remains well positioned to succeed in an evolving diabetes landscape. The stock remains a top idea." (3/1/2017)

Who are some of DexCom's key competitors?

Who are DexCom's key executives?

DexCom's management team includes the folowing people:

  • Terrance H. Gregg, Executive Chairman of the Board (Age 68)
  • Kevin R. Sayer, President, Chief Executive Officer, Director (Age 59)
  • Quentin S. Blackford, Chief Financial Officer (Age 38)
  • Donald Abbey, Executive Vice President, Quality and Information Technology (Age 50)
  • Andrew K. Balo, Executive Vice President - Clinical, Regulatory and Quality (Age 69)
  • Richard B. Doubleday, Executive Vice President, Chief Commercial Officer (Age 54)
  • Steven R. Pacelli, Executive Vice President - Strategy and Corporate Development (Age 45)
  • Heather Ace, Senior Vice President, Human Resources (Age 47)
  • Jake Leach, Senior Vice President of Research and Development (Age 39)
  • Jeffrey C. Moy, Senior Vice President - Operations (Age 56)

Who owns DexCom stock?

DexCom's stock is owned by many different of institutional and retail investors. Top institutional investors include JANUS HENDERSON GROUP PLC (10.20%), Janus Henderson Group PLC (10.15%), Baillie Gifford & Co. (6.67%), Brown Advisory Inc. (4.79%), Artisan Partners Limited Partnership (4.17%) and JPMorgan Chase & Co. (2.71%). Company insiders that own DexCom stock include Andrew K Balo, Barbara Kahn, Jacob Steven Leach, Jay S Skyler, Jeffrey Moy, Jess Roper, John Lister, Jonathan T Md Lord, Jorge A Valdes, Kevin R Sayer, Mark G Foletta, Richard Doubleday, Steven R Altman, Steven Robert Pacelli and Terrance H Gregg. View Institutional Ownership Trends for DexCom.

Who sold DexCom stock? Who is selling DexCom stock?

DexCom's stock was sold by a variety of institutional investors in the last quarter, including Ameriprise Financial Inc., Bank of New York Mellon Corp, Artisan Partners Limited Partnership, Wells Fargo & Company MN, Westfield Capital Management Co. LP, Bamco Inc. NY, Baillie Gifford & Co. and Point72 Asset Management L.P.. Company insiders that have sold DexCom company stock in the last year include Andrew K Balo, Barbara Kahn, Jacob Steven Leach, Jay S Skyler, Jess Roper, John Lister, Jorge A Valdes, Kevin R Sayer, Mark G Foletta, Richard Doubleday, Steven Robert Pacelli and Terrance H Gregg. View Insider Buying and Selling for DexCom.

Who bought DexCom stock? Who is buying DexCom stock?

DexCom's stock was acquired by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Janus Henderson Group PLC, Brown Advisory Inc., Frontier Capital Management Co. LLC, Russell Investments Group Ltd., Sessa Capital IM L.P., Mackenzie Financial Corp and Stephens Investment Management Group LLC. View Insider Buying and Selling for DexCom.

How do I buy DexCom stock?

Shares of DexCom can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DexCom's stock price today?

One share of DexCom stock can currently be purchased for approximately $58.45.

How big of a company is DexCom?

DexCom has a market capitalization of $5.35 billion and generates $573.30 million in revenue each year. The medical device company earns $-65,600,000.00 in net income (profit) each year or ($0.57) on an earnings per share basis. DexCom employs 2,300 workers across the globe.

How can I contact DexCom?

DexCom's mailing address is 6340 SEQUENCE DRIVE, SAN DIEGO CA, 92121. The medical device company can be reached via phone at 858-200-0200 or via email at [email protected]


MarketBeat Community Rating for DexCom (DXCM)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  539 (Vote Outperform)
Underperform Votes:  268 (Vote Underperform)
Total Votes:  807
MarketBeat's community ratings are surveys of what our community members think about DexCom and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

DexCom (NASDAQ:DXCM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.852.85
Ratings Breakdown: 0 Sell Rating(s)
8 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
17 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
17 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $73.43$72.83$88.88$89.88
Price Target Upside: 25.62% upside52.61% upside24.73% upside28.88% upside

DexCom (NASDAQ:DXCM) Consensus Price Target History

Price Target History for DexCom (NASDAQ:DXCM)

DexCom (NASDAQ:DXCM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/12/2017BMO Capital MarketsBoost Price TargetOutperform$74.00MediumView Rating Details
11/3/2017Morgan StanleyLower Price TargetNeutral$72.00 -> $52.00N/AView Rating Details
11/2/2017BarclaysLower Price TargetEqual Weight$60.00 -> $57.00N/AView Rating Details
11/2/2017Northland SecuritiesReiterated RatingHold$50.00N/AView Rating Details
10/4/2017WedbushReiterated RatingBuy$76.00LowView Rating Details
9/29/2017Leerink SwannReiterated RatingBuy$85.00 -> $57.00HighView Rating Details
9/29/2017Raymond James FinancialDowngradeOutperform -> Mkt PerformHighView Rating Details
9/28/2017Piper Jaffray CompaniesReiterated RatingBuy$87.00HighView Rating Details
9/28/2017StephensReiterated RatingBuy$83.00 -> $70.00HighView Rating Details
9/28/2017OppenheimerLower Price TargetOutperform$92.00 -> $85.00HighView Rating Details
9/28/2017Robert W. BairdLower Price TargetNeutral -> Neutral$79.00 -> $58.00HighView Rating Details
9/28/2017CowenLower Price TargetOutperform$90.00 -> $64.00HighView Rating Details
9/28/2017Canaccord GenuityReiterated RatingBuy$90.00 -> $69.00HighView Rating Details
9/28/2017Jefferies GroupReiterated RatingBuy$91.00HighView Rating Details
9/28/2017CitigroupDowngradeOutperform -> Market PerformHighView Rating Details
9/28/2017J P Morgan Chase & CoDowngradeOverweight -> Neutral$93.00 -> $71.00HighView Rating Details
5/7/2017B. RileyReiterated RatingBuy$95.00HighView Rating Details
5/3/2017BTIG ResearchDowngradeBuy -> NeutralHighView Rating Details
4/27/2017William BlairReiterated RatingOutperformLowView Rating Details
4/4/2017Royal Bank of CanadaReiterated RatingOutperform$87.00MediumView Rating Details
3/1/2017Northcoast ResearchReiterated RatingBuyN/AView Rating Details
9/16/2016DesjardinsUpgradeHold -> BuyN/AView Rating Details
8/3/2016BenchmarkLower Price TargetBuy$106.00 -> $86.00N/AView Rating Details
7/15/2016Deutsche BankBoost Price TargetBuy$90.00 -> $98.00N/AView Rating Details
(Data available from 12/12/2015 forward)

Earnings

DexCom (NASDAQ:DXCM) Earnings History and Estimates Chart

Earnings by Quarter for DexCom (NASDAQ:DXCM)

DexCom (NASDAQ DXCM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/26/2018$0.02N/AView Earnings Details
8/1/2017Q2 2017($0.23)($0.16)$166.54 million$170.60 millionViewListenView Earnings Details
5/2/2017Q1 2017($0.55)($0.49)$143.94 million$142.30 millionViewListenView Earnings Details
2/28/2017Q416($0.10)($0.09)$167.51 million$171.20 millionViewListenView Earnings Details
11/1/2016Q316($0.14)($0.22)$146.09 million$148.60 millionViewN/AView Earnings Details
8/2/2016Q216($0.12)($0.24)$132.48 million$137.30 millionViewN/AView Earnings Details
4/27/2016Q116($0.20)($0.23)$110.37 million$116.20 millionViewListenView Earnings Details
2/23/2016Q415$0.01$0.02$122.93 million$130.80 millionViewListenView Earnings Details
11/4/2015Q315($0.01)($0.07)$97.47 million$105.20 millionViewN/AView Earnings Details
8/5/2015Q215($0.03)($0.05)$84.74 million$93.20 millionViewN/AView Earnings Details
4/29/2015Q115($0.11)($0.17)$71.32 million$72.80 millionViewN/AView Earnings Details
2/25/2015Q414($0.03)$0.02$79.65 million$84.30 millionViewN/AView Earnings Details
11/6/2014Q314($0.05)($0.08)$60.20 million$67.90 millionViewN/AView Earnings Details
8/6/2014Q214($0.10)($0.10)$52.45 million$58.80 millionViewListenView Earnings Details
5/1/2014Q114($0.08)($0.17)$44.15 million$47.10 millionViewListenView Earnings Details
2/20/2014Q413($0.07)($0.04)$48.53 million$51.30 millionViewListenView Earnings Details
11/6/2013Q313($0.13)($0.09)$35.90 million$42.90 millionViewN/AView Earnings Details
8/7/2013Q2 2013($0.16)($0.14)$31.14 million$35.80 millionViewN/AView Earnings Details
5/1/2013Q1 2013($0.17)($0.16)$28.26 million$29.60 millionViewN/AView Earnings Details
2/21/2013Q4 2012($0.15)($0.12)$31.09 million$33.30 millionViewN/AView Earnings Details
11/1/2012Q312($0.22)($0.25)$23.14 million$23.10 millionViewN/AView Earnings Details
8/6/2012($0.20)($0.21)ViewN/AView Earnings Details
5/2/2012($0.19)($0.21)ViewN/AView Earnings Details
2/23/2012($0.17)($0.18)ViewN/AView Earnings Details
11/2/2011($0.15)($0.20)ViewN/AView Earnings Details
8/3/2011($0.11)($0.11)ViewN/AView Earnings Details
5/3/2011($0.19)($0.19)ViewN/AView Earnings Details
3/3/2011($0.19)($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

DexCom (NASDAQ:DXCM) Earnings Estimates

2017 EPS Consensus Estimate: ($0.75)
2018 EPS Consensus Estimate: ($0.19)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20178($0.68)($0.19)($0.53)
Q2 20178($0.28)($0.12)($0.19)
Q3 20178($0.18)$0.06($0.10)
Q4 20178($0.09)$0.31$0.07
Q1 20185($0.24)($0.13)($0.18)
Q2 20185($0.13)$0.05($0.06)
Q3 20185($0.12)$0.15($0.01)
Q4 20185($0.10)$0.28$0.06
(Data provided by Zacks Investment Research)

Dividends

Dividend History for DexCom (NASDAQ:DXCM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

DexCom (NASDAQ DXCM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.70%
Insider Trades by Quarter for DexCom (NASDAQ:DXCM)
Institutional Ownership by Quarter for DexCom (NASDAQ:DXCM)

DexCom (NASDAQ DXCM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/29/2017Andrew K. BaloEVPSell6,490$60.00$389,400.00View SEC Filing  
11/27/2017Mark G FolettaDirectorSell2,500$54.95$137,375.00View SEC Filing  
11/24/2017Richard DoubledayEVPSell1,635$55.53$90,791.55View SEC Filing  
11/20/2017Barbara KahnDirectorSell3,000$54.58$163,740.00View SEC Filing  
11/20/2017Kevin R. SayerCEOSell12,000$55.00$660,000.00View SEC Filing  
11/6/2017Steven R AltmanDirectorBuy10,000$49.61$496,100.00View SEC Filing  
10/23/2017Richard DoubledayEVPSell1,635$44.82$73,280.70View SEC Filing  
9/25/2017Steven Robert PacelliEVPSell1,450$69.81$101,224.50View SEC Filing  
9/20/2017Kevin R. SayerCEOSell6,000$69.34$416,040.00View SEC Filing  
9/11/2017Andrew K. BaloEVPSell3,244$72.27$234,443.88View SEC Filing  
8/23/2017Richard DoubledayEVPSell1,635$75.26$123,050.10View SEC Filing  
8/11/2017Kevin R. SayerCEOSell6,000$69.77$418,620.00View SEC Filing  
8/10/2017Andrew K. BaloEVPSell3,244$71.18$230,907.92View SEC Filing  
7/24/2017Steven Robert PacelliEVPSell1,450$69.47$100,731.50View SEC Filing  
7/12/2017Kevin R. SayerCEOSell6,000$71.86$431,160.00View SEC Filing  
7/10/2017Andrew K. BaloEVPSell3,200$71.55$228,960.00View SEC Filing  
6/23/2017Steven Robert PacelliEVPSell1,450$78.19$113,375.50View SEC Filing  
6/12/2017Andrew K. BaloEVPSell3,200$69.06$220,992.00View SEC Filing  
6/12/2017Kevin R. SayerCEOSell6,000$69.07$414,420.00View SEC Filing  
5/23/2017Richard DoubledayEVPSell3,182$68.29$217,298.78View SEC Filing  
5/17/2017Kevin R SayerCEOSell8,649$68.39$591,505.11View SEC Filing  
5/10/2017Andrew K. BaloEVPSell3,200$71.93$230,176.00View SEC Filing  
4/24/2017Richard DoubledayEVPSell3,182$75.78$241,131.96View SEC Filing  
4/20/2017Terrance H GreggInsiderSell15,000$74.10$1,111,500.00View SEC Filing  
4/17/2017Kevin R SayerCEOSell10,000$75.63$756,300.00View SEC Filing  
4/10/2017Andrew K. BaloEVPSell3,200$78.19$250,208.00View SEC Filing  
3/23/2017Richard DoubledayEVPSell3,182$76.38$243,041.16View SEC Filing  
3/22/2017Jess RoperCFOSell2,000$75.97$151,940.00View SEC Filing  
3/17/2017Kevin R SayerCEOSell10,000$77.82$778,200.00View SEC Filing  
3/14/2017Jacob Steven LeachSVPSell21,317$77.63$1,654,838.71View SEC Filing  
3/13/2017Jorge A. ValdesInsiderSell14,400$77.74$1,119,456.00View SEC Filing  
3/9/2017John ListerInsiderSell3,000$77.67$233,010.00View SEC Filing  
3/6/2017Jay S SkylerDirectorSell31,890$78.13$2,491,565.70View SEC Filing  
2/23/2017Richard DoubledayEVPSell3,182$78.42$249,532.44View SEC Filing  
1/23/2017Richard DoubledayEVPSell3,182$79.50$252,969.00View SEC Filing  
1/18/2017Jess RoperCFOSell3,012$85.01$256,050.12View SEC Filing  
1/17/2017Kevin R SayerCEOSell10,000$85.94$859,400.00View SEC Filing  
1/13/2017John ListerInsiderSell15,000$79.36$1,190,400.00View SEC Filing  
1/10/2017Andrew K BaloEVPSell3,200$62.86$201,152.00View SEC Filing  
1/9/2017Jorge A ValdesInsiderSell10,900$63.02$686,918.00View SEC Filing  
12/23/2016Richard DoubledayEVPSell3,182$62.17$197,824.94View SEC Filing  
12/9/2016Jorge A ValdesInsiderSell10,000$64.81$648,100.00View SEC Filing  
10/24/2016Jess RoperCFOSell2,471$80.75$199,533.25View SEC Filing  
10/24/2016Steven Robert PacelliEVPSell10,300$81.95$844,085.00View SEC Filing  
10/19/2016Andrew K. BaloEVPSell4,997$82.31$411,303.07View SEC Filing  
10/14/2016Kevin R. SayerCEOSell7,000$81.87$573,090.00View SEC Filing  
10/10/2016John ListerInsiderSell3,560$84.41$300,499.60View SEC Filing  
10/5/2016Andrew K. BaloEVPSell5,000$82.55$412,750.00View SEC Filing  
9/23/2016Richard DoubledayEVPSell3,182$93.97$299,012.54View SEC Filing  
9/22/2016Jess RoperCFOSell2,470$93.99$232,155.30View SEC Filing  
9/21/2016Andrew K. BaloEVPSell5,000$92.87$464,350.00View SEC Filing  
9/14/2016Kevin R. SayerCEOSell7,000$91.79$642,530.00View SEC Filing  
9/12/2016Jay S SkylerDirectorSell10,000$93.00$930,000.00View SEC Filing  
9/12/2016Jorge A ValdesInsiderSell19,071$93.07$1,774,937.97View SEC Filing  
9/9/2016Jay S SkylerDirectorSell25,000$94.07$2,351,750.00View SEC Filing  
9/9/2016John ListerInsiderSell3,560$93.65$333,394.00View SEC Filing  
9/8/2016Terrance H GreggInsiderSell10,740$95.29$1,023,414.60View SEC Filing  
9/7/2016Andrew K BaloEVPSell4,999$94.45$472,155.55View SEC Filing  
9/7/2016Mark G. FolettaDirectorSell1,800$94.63$170,334.00View SEC Filing  
9/1/2016Jonathan T. Md LordDirectorSell10,000$91.50$915,000.00View SEC Filing  
8/30/2016Terrance H GreggInsiderSell10,000$92.14$921,400.00View SEC Filing  
8/24/2016Andrew K BaloEVPSell5,000$91.72$458,600.00View SEC Filing  
8/24/2016Terrance H GreggInsiderSell10,000$92.72$927,200.00View SEC Filing  
8/23/2016Steven Robert PacelliEVPSell10,300$90.74$934,622.00View SEC Filing  
8/23/2016Terrance H GreggChairmanSell10,000$91.11$911,100.00View SEC Filing  
8/22/2016Terrance H GreggChairmanSell10,000$90.51$905,100.00View SEC Filing  
8/19/2016Jay S SkylerDirectorSell25,000$90.77$2,269,250.00View SEC Filing  
8/19/2016Terrance H GreggInsiderSell40,000$90.70$3,628,000.00View SEC Filing  
8/15/2016Kevin R. SayerCEOSell7,000$90.78$635,460.00View SEC Filing  
8/15/2016Terrance H GreggChairmanSell14,942$91.01$1,359,871.42View SEC Filing  
8/12/2016Jonathan T. Md LordDirectorSell10,000$90.64$906,400.00View SEC Filing  
8/11/2016Terrance H GreggInsiderSell10,900$91.03$992,227.00View SEC Filing  
8/10/2016Andrew K BaloEVPSell5,000$90.26$451,300.00View SEC Filing  
8/9/2016Jorge A ValdesInsiderSell32,000$91.06$2,913,920.00View SEC Filing  
8/9/2016Kevin R SayerCEOSell20,000$90.98$1,819,600.00View SEC Filing  
8/8/2016Barbara KahnDirectorSell6,000$90.52$543,120.00View SEC Filing  
8/5/2016Terrance H. GreggInsiderSell35,000$79.81$2,793,350.00View SEC Filing  
8/1/2016Jeffrey MoySVPSell15,000$92.33$1,384,950.00View SEC Filing  
7/27/2016Andrew K BaloEVPSell5,000$88.14$440,700.00View SEC Filing  
7/25/2016Richard DoubledayEVPSell3,182$87.31$277,820.42View SEC Filing  
7/22/2016Jeffrey MoySVPSell10,000$88.48$884,800.00View SEC Filing  
7/19/2016Jeffrey MoySVPSell12,843$83.78$1,075,986.54View SEC Filing  
7/13/2016Andrew K BaloEVPSell5,000$80.12$400,600.00View SEC Filing  
7/13/2016Kevin R. SayerCEOSell7,000$79.92$559,440.00View SEC Filing  
7/11/2016Jorge A ValdesInsiderSell32,000$79.36$2,539,520.00View SEC Filing  
6/29/2016Andrew K BaloEVPSell5,000$78.10$390,500.00View SEC Filing  
6/29/2016Jeffrey MoySVPSell4,557$80.00$364,560.00View SEC Filing  
6/23/2016Steven Robert PacelliEVPSell10,300$77.40$797,220.00View SEC Filing  
6/20/2016Andrew K BaloEVPSell55,000$75.00$4,125,000.00View SEC Filing  
6/20/2016Jeffrey MoySVPSell7,209$77.00$555,093.00View SEC Filing  
6/20/2016Kevin R. SayerCEOSell35,000$75.00$2,625,000.00View SEC Filing  
6/9/2016Jeffrey MoySVPSell6,910$74.00$511,340.00View SEC Filing  
6/9/2016John ListerInsiderSell3,560$73.27$260,841.20View SEC Filing  
6/8/2016Jeffrey MoySVPSell6,866$71.00$487,486.00View SEC Filing  
6/8/2016Jorge A ValdesInsiderSell18,038$72.06$1,299,818.28View SEC Filing  
6/8/2016Steven Robert PacelliEVPSell18,239$70.88$1,292,780.32View SEC Filing  
6/7/2016Jess RoperCFOSell3,471$69.00$239,499.00View SEC Filing  
5/23/2016Richard DoubledayEVPSell1,674$63.59$106,449.66View SEC Filing  
5/18/2016Jorge A ValdesInsiderSell20,000$61.75$1,235,000.00View SEC Filing  
5/16/2016Terrance H GreggChairmanSell20,000$62.72$1,254,400.00View SEC Filing  
5/12/2016Barbara KahnDirectorSell3,000$60.72$182,160.00View SEC Filing  
5/11/2016Terrance H GreggChairmanSell8,600$64.32$553,152.00View SEC Filing  
5/9/2016John ListerInsiderSell3,560$62.50$222,500.00View SEC Filing  
5/9/2016Terrance H GreggChairmanSell12,168$62.42$759,526.56View SEC Filing  
4/27/2016Jorge A ValdesInsiderSell10,000$70.00$700,000.00View SEC Filing  
4/27/2016Steven Robert PacelliEVPSell2,361$70.39$166,190.79View SEC Filing  
4/25/2016Jess RoperCFOSell3,471$69.00$239,499.00View SEC Filing  
4/25/2016Richard DoubledayEVPSell1,666$69.15$115,203.90View SEC Filing  
4/12/2016John ListerInsiderSell3,704$65.78$243,649.12View SEC Filing  
4/11/2016Terrance H GreggChairmanSell2,169$68.00$147,492.00View SEC Filing  
4/4/2016Jorge A ValdesInsiderSell20,000$70.08$1,401,600.00View SEC Filing  
4/4/2016Steven Robert PacelliEVPSell20,600$70.62$1,454,772.00View SEC Filing  
3/31/2016Jess RoperCFOSell3,470$69.00$239,430.00View SEC Filing  
3/23/2016Richard DoubledayEVPSell1,666$61.76$102,892.16View SEC Filing  
3/22/2016Terrance H GreggChairmanSell25,000$59.51$1,487,750.00View SEC Filing  
3/14/2016John ListerInsiderSell3,560$63.75$226,950.00View SEC Filing  
3/7/2016Barbara KahnDirectorSell5,000$67.04$335,200.00View SEC Filing  
2/23/2016Richard DoubledayEVPSell1,666$64.36$107,223.76View SEC Filing  
2/18/2016John ListerVPSell3,560$62.50$222,500.00View SEC Filing  
1/25/2016Steven Robert PacelliEVPSell10,300$73.24$754,372.00View SEC Filing  
1/22/2016Jess RoperCFOSell3,518$72.97$256,708.46View SEC Filing  
1/20/2016Kevin R SayerCEOSell7,000$75.00$525,000.00View SEC Filing  
1/12/2016Jorge A ValdesInsiderSell5,610$80.16$449,697.60View SEC Filing  
1/11/2016Jorge A ValdesInsiderSell1,641$78.43$128,703.63View SEC Filing  
1/8/2016John ListerVPSell3,560$82.57$293,949.20View SEC Filing  
12/23/2015Richard DoubledayEVPSell1,666$82.22$136,978.52View SEC Filing  
12/22/2015Jess RoperCFOSell3,417$81.19$277,426.23View SEC Filing  
12/17/2015Andrew K. BaloEVPSell7,500$82.52$618,900.00View SEC Filing  
12/14/2015John ListerVPSell3,560$82.50$293,700.00View SEC Filing  
12/9/2015Jorge A. ValdesinsiderSell10,000$85.74$857,400.00View SEC Filing  
12/8/2015John ListerVPSell2,476$87.16$215,808.16View SEC Filing  
12/4/2015Terrance H. GreggChairmanSell10,000$86.79$867,900.00View SEC Filing  
12/3/2015Andrew K. BaloEVPSell7,500$86.37$647,775.00View SEC Filing  
12/2/2015Terrance H. GreggChairmanSell10,000$87.05$870,500.00View SEC Filing  
11/30/2015Terrance H. GreggChairmanSell5,000$86.50$432,500.00View SEC Filing  
11/25/2015Andrew K. BaloEVPSell7,500$87.49$656,175.00View SEC Filing  
11/25/2015Terrance H. GreggChairmanSell15,000$87.53$1,312,950.00View SEC Filing  
11/24/2015Andrew K. BaloEVPSell10,000$86.43$864,300.00View SEC Filing  
11/24/2015Terrance H. GreggChairmanSell15,497$86.54$1,341,110.38View SEC Filing  
11/23/2015Richard DoubledayEVPSell1,666$85.85$143,026.10View SEC Filing  
11/20/2015Terrance H. GreggChairmanSell22,003$86.48$1,902,819.44View SEC Filing  
11/18/2015Jess RoperCFOSell7,000$84.15$589,050.00View SEC Filing  
11/16/2015Terrance H. GreggChairmanSell20,000$83.89$1,677,800.00View SEC Filing  
11/12/2015Jess RoperCFOSell20,000$84.07$1,681,400.00View SEC Filing  
11/11/2015Andrew K. BaloEVPSell7,500$84.50$633,750.00View SEC Filing  
10/23/2015Richard DoubledayEVPSell1,666$79.27$132,063.82View SEC Filing  
10/20/2015Andrew K BaloEVPSell4,538$81.46$369,665.48View SEC Filing  
10/19/2015Jess RoperCFOSell7,000$83.37$583,590.00View SEC Filing  
10/15/2015Terrance H GreggChairmanSell15,000$77.92$1,168,800.00View SEC Filing  
10/6/2015Andrew K BaloEVPSell8,216$82.29$676,094.64View SEC Filing  
9/23/2015Steven Robert PacelliEVPSell14,000$98.08$1,373,120.00View SEC Filing  
9/21/2015Andrew K BaloEVPSell7,859$100.72$791,558.48View SEC Filing  
9/18/2015Jess RoperCFOSell7,000$101.22$708,540.00View SEC Filing  
9/15/2015Terrance H. GreggChairmanSell29,999$96.22$2,886,503.78View SEC Filing  
9/11/2015Terrance H. GreggChairmanSell47,500$96.50$4,583,750.00View SEC Filing  
9/10/2015Terrance H. GreggChairmanSell62,501$95.91$5,994,470.91View SEC Filing  
9/9/2015Jonathan T Md LordDirectorSell10,000$90.96$909,600.00View SEC Filing  
9/8/2015Andrew K BaloEVPSell7,500$89.53$671,475.00View SEC Filing  
9/8/2015John ListerVPSell2,642$89.36$236,089.12View SEC Filing  
9/8/2015Terrance H. GreggChairmanSell25,000$90.85$2,271,250.00View SEC Filing  
9/1/2015Jeffrey MoySVPSell8,881$90.61$804,707.41View SEC Filing  
9/1/2015Jorge A. ValdesinsiderSell20,000$91.22$1,824,400.00View SEC Filing  
8/28/2015Steven Robert PacelliEVPSell19,854$94.67$1,879,578.18View SEC Filing  
8/24/2015Steven Robert PacelliEVPSell14,000$84.18$1,178,520.00View SEC Filing  
8/20/2015Andrew K BaloEVPSell7,500$92.47$693,525.00View SEC Filing  
8/18/2015Steven R AltmanDirectorSell5,000$96.69$483,450.00View SEC Filing  
8/17/2015Jay S SkylerDirectorSell20,000$96.65$1,933,000.00View SEC Filing  
8/17/2015Terrance H GreggChairmanSell15,000$96.71$1,450,650.00View SEC Filing  
8/14/2015Kevin R SayerCEOSell35,000$97.41$3,409,350.00View SEC Filing  
7/23/2015Richard DoubledayEVPSell9,641$85.37$823,052.17View SEC Filing  
7/22/2015Andrew K BaloEVPSell10,214$84.78$865,942.92View SEC Filing  
7/21/2015Jeffrey MoySVPSell3,786$83.48$316,055.28View SEC Filing  
7/20/2015Jess RoperCFOSell7,000$83.74$586,180.00View SEC Filing  
7/17/2015Terrance H GreggChairmanSell50,750$83.07$4,215,802.50View SEC Filing  
7/15/2015Jay S SkylerDirectorSell20,000$81.69$1,633,800.00View SEC Filing  
7/8/2015Andrew K BaloEVPSell4,494$80.22$360,508.68View SEC Filing  
7/8/2015John ListerVPSell1,776$79.94$141,973.44View SEC Filing  
7/8/2015Jorge A ValdesInsiderSell50,000$79.83$3,991,500.00View SEC Filing  
7/7/2015Jeffrey MoySVPSell5,000$79.32$396,600.00View SEC Filing  
6/23/2015Jeffrey MoySVPSell5,154$77.54$399,641.16View SEC Filing  
6/23/2015Steven Robert PacelliEVPSell14,000$77.53$1,085,420.00View SEC Filing  
6/18/2015Jess RoperCFOSell7,000$77.10$539,700.00View SEC Filing  
6/15/2015Jay S SkylerDirectorSell20,000$70.67$1,413,400.00View SEC Filing  
6/15/2015Terrance H GreggChairmanSell15,000$70.94$1,064,100.00View SEC Filing  
6/12/2015Terrance H. GreggChairmanSell25,000$72.30$1,807,500.00View SEC Filing  
6/11/2015Jeffrey MoySVPSell9,869$73.00$720,437.00View SEC Filing  
6/9/2015Andrew K BaloEVPSell7,500$70.62$529,650.00View SEC Filing  
6/9/2015Jeffrey MoySVPSell5,000$70.63$353,150.00View SEC Filing  
6/9/2015Jorge A ValdesInsiderSell19,680$71.32$1,403,577.60View SEC Filing  
6/8/2015John ListerVPSell1,776$72.03$127,925.28View SEC Filing  
6/8/2015Jorge A ValdesInsiderSell8,243$72.07$594,073.01View SEC Filing  
6/3/2015Terrance H GreggChairmanSell40,000$72.77$2,910,800.00View SEC Filing  
6/2/2015Terrance H GreggChairmanSell5,000$73.12$365,600.00View SEC Filing  
6/1/2015Terrance H GreggChairmanSell10,000$72.75$727,500.00View SEC Filing  
5/27/2015Jeffrey MoySVPSell21,791$69.60$1,516,653.60View SEC Filing  
5/27/2015Richard DoubledayEVPSell3,258$70.73$230,438.34View SEC Filing  
5/18/2015Andrew K BaloEVPSell7,500$68.46$513,450.00View SEC Filing  
5/18/2015Jeffrey MoySVPSell15,586$69.20$1,078,551.20View SEC Filing  
5/18/2015Jess RoperCFOSell7,000$69.27$484,890.00View SEC Filing  
5/15/2015Terrance H GreggChairmanSell82,500$69.24$5,712,300.00View SEC Filing  
5/12/2015Jeffrey MoySVPSell20,303$67.84$1,377,355.52View SEC Filing  
5/12/2015Jorge A ValdesInsiderSell30,878$68.27$2,108,041.06View SEC Filing  
5/11/2015Jeffrey MoySVPSell15,303$68.25$1,044,429.75View SEC Filing  
5/11/2015Terrance H GreggChairmanSell3,517$68.65$241,442.05View SEC Filing  
5/8/2015Terrance H GreggChairmanSell91,483$67.85$6,207,121.55View SEC Filing  
5/4/2015Kevin R SayerCEOSell25,000$68.01$1,700,250.00View SEC Filing  
4/28/2015Jeffrey MoySVPSell10,000$68.41$684,100.00View SEC Filing  
4/27/2015Jeffrey MoySVPSell5,000$69.27$346,350.00View SEC Filing  
4/23/2015Steven Robert PacelliEVPSell39,709$69.63$2,764,937.67View SEC Filing  
4/20/2015Jess RoperCFOSell7,000$68.05$476,350.00View SEC Filing  
4/15/2015Terrance H GreggChairmanSell15,000$67.56$1,013,400.00View SEC Filing  
4/14/2015Jeffrey MoySVPSell20,766$66.63$1,383,638.58View SEC Filing  
4/9/2015Andrew K BaloEVPSell7,500$64.55$484,125.00View SEC Filing  
4/9/2015Jorge A ValdesInsiderSell19,684$64.38$1,267,255.92View SEC Filing  
4/8/2015John ListerVPSell5,039$63.84$321,689.76View SEC Filing  
3/25/2015Andrew K BaloEVPSell7,500$61.05$457,875.00View SEC Filing  
3/23/2015Steven Robert PacelliEVPSell14,000$61.33$858,620.00View SEC Filing  
3/18/2015Jess RoperCFOSell7,000$62.43$437,010.00View SEC Filing  
3/17/2015Terrance H GreggChairmanSell15,000$62.82$942,300.00View SEC Filing  
3/13/2015Jay S SkylerDirectorSell45,000$60.01$2,700,450.00View SEC Filing  
3/12/2015Jorge A ValdesInsiderSell11,138$59.78$665,829.64View SEC Filing  
3/12/2015Richard DoubledayEVPSell20,000$59.23$1,184,600.00View SEC Filing  
3/9/2015John ListerVPSell5,039$58.77$296,142.03View SEC Filing  
3/9/2015Jorge A ValdesInsiderSell8,244$58.77$484,499.88View SEC Filing  
2/23/2015Richard DoubledayEVPSell4,000$63.58$254,320.00View SEC Filing  
2/9/2015John ListerVPSell5,039$61.66$310,704.74View SEC Filing  
2/9/2015Jorge A ValdesInsiderSell8,244$61.67$508,407.48View SEC Filing  
2/2/2015Jeffrey MoySVPSell5,000$60.69$303,450.00View SEC Filing  
1/26/2015Steven Robert PacelliEVPSell24,532$59.67$1,463,824.44View SEC Filing  
1/23/2015Richard DoubledayEVPSell4,000$58.22$232,880.00View SEC Filing  
1/20/2015Jeffrey MoySVPSell5,000$57.58$287,900.00View SEC Filing  
1/20/2015Jess RoperCFOSell7,000$57.34$401,380.00View SEC Filing  
1/15/2015Terrance H GreggChairmanSell15,000$57.84$867,600.00View SEC Filing  
1/13/2015Steven Robert PacelliEVPSell9,468$62.22$589,098.96View SEC Filing  
1/12/2015Steven Robert PacelliEVPSell20,000$59.18$1,183,600.00View SEC Filing  
1/9/2015Jorge A ValdesInsiderSell9,170$57.55$527,733.50View SEC Filing  
1/8/2015John ListerVPSell5,039$57.42$289,339.38View SEC Filing  
1/5/2015Jeffrey MoySVPSell5,000$55.27$276,350.00View SEC Filing  
12/26/2014Andrew K BaloSVPSell10,000$55.27$552,700.00View SEC Filing  
12/23/2014Richard DoubledayVPSell4,000$54.69$218,760.00View SEC Filing  
12/23/2014Steven Robert PacelliEVPSell14,000$54.62$764,680.00View SEC Filing  
12/18/2014Jess RoperCFOSell12,000$56.43$677,160.00View SEC Filing  
12/15/2014Terrance H GreggCEOSell35,000$53.23$1,863,050.00View SEC Filing  
12/8/2014Jorge A ValdesInsiderSell16,000$56.03$896,480.00View SEC Filing  
12/3/2014Eric TopolDirectorSell20,000$55.00$1,100,000.00View SEC Filing  
11/28/2014Terrance H GreggCEOSell59,990$51.51$3,090,084.90View SEC Filing  
11/25/2014Andrew K BaloSVPSell10,000$51.11$511,100.00View SEC Filing  
11/25/2014Terrance H GreggCEOSell55,010$51.04$2,807,710.40View SEC Filing  
11/24/2014Richard DoubledayVPSell4,000$50.36$201,440.00View SEC Filing  
11/24/2014Terrance H GreggCEOSell35,000$51.06$1,787,100.00View SEC Filing  
11/21/2014Terrance H GreggCEOSell10,000$50.50$505,000.00View SEC Filing  
11/19/2014Terrance H GreggCEOSell10,000$51.00$510,000.00View SEC Filing  
11/17/2014Terrance H GreggCEOSell45,000$52.52$2,363,400.00View SEC Filing  
11/12/2014Terrance H GreggCEOSell80,000$53.36$4,268,800.00View SEC Filing  
11/10/2014Jorge A ValdesInsiderSell16,000$51.23$819,680.00View SEC Filing  
10/27/2014Andrew K BaloSVPSell10,000$42.98$429,800.00View SEC Filing  
10/23/2014Richard DoubledayVPSell4,000$43.58$174,320.00View SEC Filing  
10/23/2014Steven Robert PacelliEVPSell14,000$43.60$610,400.00View SEC Filing  
10/13/2014Andrew K BaloSVPSell10,000$40.42$404,200.00View SEC Filing  
10/13/2014John ListerVPSell3,400$40.41$137,394.00View SEC Filing  
10/8/2014Jorge A ValdesInsiderSell16,000$40.29$644,640.00View SEC Filing  
9/25/2014Andrew K BaloSVPSell10,000$40.71$407,100.00View SEC Filing  
9/23/2014Richard DoubledayVPSell4,000$40.32$161,280.00View SEC Filing  
9/23/2014Steven Robert PacelliEVPSell14,000$40.32$564,480.00View SEC Filing  
9/18/2014Jess RoperCFOSell8,000$41.91$335,280.00View SEC Filing  
9/15/2014Terrance H GreggCEOSell35,000$41.14$1,439,900.00View SEC Filing  
9/12/2014John ListerVPSell3,518$43.70$153,736.60View SEC Filing  
9/11/2014Andrew K BaloSVPSell10,000$42.97$429,700.00View SEC Filing  
9/8/2014Jorge A ValdesInsiderSell16,000$42.98$687,680.00View SEC Filing  
8/28/2014Barbara KahnDirectorSell4,000$44.52$178,080.00View SEC Filing  
8/26/2014Jeffrey MoySVPSell16,663$45.30$754,833.90View SEC Filing  
8/26/2014Jonathan T Md LordDirectorSell20,000$45.56$911,200.00View SEC Filing  
8/26/2014Steven Robert PacelliEVPSell30,000$44.56$1,336,800.00View SEC Filing  
8/26/2014Terrance H GreggCEOSell5,000$46.05$230,250.00View SEC Filing  
8/25/2014Andrew K BaloSVPSell10,000$44.12$441,200.00View SEC Filing  
8/25/2014Richard DoubledayVPSell4,000$44.35$177,400.00View SEC Filing  
8/25/2014Steven Robert PacelliEVPSell14,000$44.24$619,360.00View SEC Filing  
8/22/2014Andrew K BaloSVPSell20,000$44.24$884,800.00View SEC Filing  
8/22/2014Terrance H GreggCEOSell13,607$44.46$604,967.22View SEC Filing  
8/21/2014Barbara KahnDirectorSell2,200$43.42$95,524.00View SEC Filing  
8/21/2014Jorge A ValdesInsiderSell10,671$43.58$465,042.18View SEC Filing  
8/21/2014Terrance H GreggCEOSell23,893$44.36$1,059,893.48View SEC Filing  
8/19/2014Richard DoubledayVPSell20,000$45.01$900,200.00View SEC Filing  
8/19/2014Terrance H GreggCEOSell75,000$45.08$3,381,000.00View SEC Filing  
8/18/2014Terrance H GreggCEOSell65,000$44.16$2,870,400.00View SEC Filing  
8/14/2014Terrance H GreggCEOSell25,000$44.24$1,106,000.00View SEC Filing  
8/13/2014Terrance H GreggCEOSell56,107$43.57$2,444,581.99View SEC Filing  
8/11/2014Andrew K BaloSVPSell10,000$44.24$442,400.00View SEC Filing  
8/11/2014Kevin R SayerCOOSell20,000$43.82$876,400.00View SEC Filing  
8/8/2014Jorge A ValdesInsiderSell16,000$43.56$696,960.00View SEC Filing  
7/25/2014Andrew K BaloSVPSell10,000$38.19$381,900.00View SEC Filing  
7/23/2014Richard DoubledayVPSell4,000$38.16$152,640.00View SEC Filing  
7/23/2014Steven Robert PacelliEVPSell14,000$38.28$535,920.00View SEC Filing  
7/18/2014Jess RoperCFOSell8,000$36.01$288,080.00View SEC Filing  
7/15/2014Terrance H GreggCEOSell35,000$36.66$1,283,100.00View SEC Filing  
7/14/2014John ListerVPSell3,500$36.59$128,065.00View SEC Filing  
7/11/2014Andrew K BaloSVPSell10,000$35.93$359,300.00View SEC Filing  
7/8/2014Jorge A ValdesInsiderSell16,000$36.66$586,560.00View SEC Filing  
7/2/2014Jay S SkylerDirectorSell30,000$40.05$1,201,500.00View SEC Filing  
6/25/2014Andrew K BaloSVPSell10,000$40.60$406,000.00View SEC Filing  
6/23/2014Richard DoubledayVPSell4,000$40.98$163,920.00View SEC Filing  
6/23/2014Steven Robert PacelliEVPSell14,000$41.02$574,280.00View SEC Filing  
6/20/2014Jay S SkylerDirectorSell60,000$40.00$2,400,000.00View SEC Filing  
6/18/2014Jess RoperCFOSell8,000$39.17$313,360.00View SEC Filing  
6/16/2014Terrance H GreggCEOSell35,000$37.23$1,303,050.00View SEC Filing  
6/12/2014John ListerVPSell3,500$36.13$126,455.00View SEC Filing  
6/11/2014Andrew K BaloSVPSell10,000$36.63$366,300.00View SEC Filing  
6/9/2014Jorge A ValdesInsiderSell16,000$36.68$586,880.00View SEC Filing  
6/5/2014Richard DoubledayVPSell4,000$35.59$142,360.00View SEC Filing  
5/27/2014Andrew K BaloSVPSell10,000$33.86$338,600.00View SEC Filing  
5/19/2014Jess RoperCFOSell8,000$32.20$257,600.00View SEC Filing  
5/8/2014Jorge ValdesInsiderSell16,000$29.83$477,280.00View SEC Filing  
4/25/2014Andrew BaloSVPSell10,000$34.35$343,500.00View SEC Filing  
4/23/2014Richard DoubledayVPSell4,000$35.92$143,680.00View SEC Filing  
4/23/2014Steven Robert PacelliEVPSell14,000$35.90$502,600.00View SEC Filing  
4/21/2014Jess RoperCFOSell8,000$36.18$289,440.00View SEC Filing  
4/15/2014Terrance GreggCEOSell35,000$34.09$1,193,150.00View SEC Filing  
4/14/2014John ListerVPSell2,884$35.86$103,420.24View SEC Filing  
4/11/2014Andrew BaloSVPSell10,000$35.36$353,600.00View SEC Filing  
4/8/2014Jorge ValdesInsiderSell16,000$35.99$575,840.00View SEC Filing  
3/26/2014Jay SkylerDirectorSell30,000$43.05$1,291,500.00View SEC Filing  
3/25/2014Andrew BaloSVPSell10,000$43.00$430,000.00View SEC Filing  
3/24/2014Steven Robert PacelliEVPSell14,000$42.92$600,880.00View SEC Filing  
3/18/2014Jess RoperCFOSell8,000$46.00$368,000.00View SEC Filing  
3/17/2014Terrance GreggCEOSell45,000$45.25$2,036,250.00View SEC Filing  
3/12/2014Terrance GreggCEOSell30,000$45.50$1,365,000.00View SEC Filing  
3/10/2014Jorge ValdesInsiderSell16,000$46.57$745,120.00View SEC Filing  
3/5/2014Jeffrey MoySVPSell10,000$47.30$473,000.00View SEC Filing  
3/5/2014Terrance GreggCEOSell111,890$47.46$5,310,299.40View SEC Filing  
3/3/2014Terrance GreggCEOSell40,000$44.87$1,794,800.00View SEC Filing  
2/26/2014Jess RoperCFOSell25,000$45.20$1,130,000.00View SEC Filing  
2/25/2014Steven Robert PacelliEVPSell33,368$44.93$1,499,224.24View SEC Filing  
1/23/2014Steven Robert PacelliEVPSell14,000$36.49$510,860.00View SEC Filing  
1/21/2014Jess RoperCFOSell8,000$37.38$299,040.00View SEC Filing  
12/18/2013Jess RoperCFOSell8,000$34.48$275,840.00View SEC Filing  
12/13/2013Terrance GreggCEOSell50,000$34.41$1,720,500.00View SEC Filing  
12/12/2013Nicholas AugustinosDirectorSell11,321$34.40$389,442.40View SEC Filing  
12/10/2013Nicholas AugustinosDirectorSell97,541$33.64$3,281,279.24View SEC Filing  
12/5/2013Terrance GreggCEOSell20,000$34.77$695,400.00View SEC Filing  
12/3/2013Andrew BaloSVPSell14,268$34.21$488,108.28View SEC Filing  
11/15/2013Terrance GreggCEOSell35,000$32.74$1,145,900.00View SEC Filing  
9/3/2013Terrance GreggCEOSell9,000$27.00$243,000.00View SEC Filing  
8/1/2013Terrance H GreggCEOSell9,000$22.15$199,350.00View SEC Filing  
7/1/2013Terrance H GreggCEOSell9,000$22.87$205,830.00View SEC Filing  
6/13/2013Andrew K BaloSVPSell10,000$21.90$219,000.00View SEC Filing  
6/11/2013Jess RoperCFOSell10,361$22.33$231,361.13View SEC Filing  
6/11/2013John ListerVPSell2,000$22.43$44,860.00View SEC Filing  
6/11/2013Steven Robert PacelliEVPSell5,000$22.31$111,550.00View SEC Filing  
6/4/2013Terrance H GreggCEOSell19,000$21.32$405,080.00View SEC Filing  
5/15/2013Jeffrey MoySVPSell5,000$19.97$99,850.00View SEC Filing  
5/13/2013Andrew K BaloSVPSell45,000$19.40$873,000.00View SEC Filing  
5/9/2013Richard DoubledaySVPSell1,272$19.56$24,880.32View SEC Filing  
3/13/2013Andrew K BaloSVPSell15,416$16.53$254,826.48View SEC Filing  
3/11/2013Jay S SkylerDirectorBuy70,000$15.50$1,085,000.00View SEC Filing  
3/11/2013John ListerVPSell4,500$15.75$70,875.00View SEC Filing  
3/11/2013Richard DoubledaySVPSell5,100$15.63$79,713.00View SEC Filing  
2/1/2013Terrance H GreggCEOSell9,000$15.08$135,720.00View SEC Filing  
12/3/2012Terrance H GreggCEOSell5,000$13.24$66,200.00View SEC Filing  
9/4/2012Terrance H GreggCEOSell15,000$13.46$201,900.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

DexCom (NASDAQ DXCM) News Headlines

Source:
DateHeadline
BMO Capital Markets Boosts DexCom (DXCM) Price Target to $74.00BMO Capital Markets Boosts DexCom (DXCM) Price Target to $74.00
www.americanbankingnews.com - December 12 at 11:28 AM
ETFs with exposure to DexCom, Inc. : December 8, 2017ETFs with exposure to DexCom, Inc. : December 8, 2017
finance.yahoo.com - December 8 at 5:03 PM
Stock Review for Medical Researchs Investors -- HTG Molecular Diagnostics, OpGen, Sorrento Tech, and DexComStock Review for Medical Research's Investors -- HTG Molecular Diagnostics, OpGen, Sorrento Tech, and DexCom
www.prnewswire.com - December 7 at 6:25 AM
DexCom, Inc. (DXCM) EVP Andrew K. Balo Sells 6,490 SharesDexCom, Inc. (DXCM) EVP Andrew K. Balo Sells 6,490 Shares
www.americanbankingnews.com - November 30 at 10:34 PM
Insider Selling: DexCom, Inc. (DXCM) Director Sells 2,500 Shares of StockInsider Selling: DexCom, Inc. (DXCM) Director Sells 2,500 Shares of Stock
www.americanbankingnews.com - November 29 at 8:22 PM
Market Trends Toward New Normal in DexCom, Charter Communications, Coca-Cola, Kemet, Superior Energy Services, and Centennial Resource Development — Emerging Consolidated Expectations, Analyst RatingsMarket Trends Toward New Normal in DexCom, Charter Communications, Coca-Cola, Kemet, Superior Energy Services, and Centennial Resource Development — Emerging Consolidated Expectations, Analyst Ratings
finance.yahoo.com - November 28 at 8:47 AM
DexCom, Inc. (DXCM) EVP Sells $90,791.55 in StockDexCom, Inc. (DXCM) EVP Sells $90,791.55 in Stock
www.americanbankingnews.com - November 27 at 8:20 PM
ETFs with exposure to DexCom, Inc. : November 27, 2017ETFs with exposure to DexCom, Inc. : November 27, 2017
finance.yahoo.com - November 27 at 5:59 PM
DexCom, Inc. (DXCM) Given Average Recommendation of "Buy" by AnalystsDexCom, Inc. (DXCM) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - November 26 at 5:24 AM
 Analysts Expect DexCom, Inc. (DXCM) Will Post Quarterly Sales of $211.91 Million Analysts Expect DexCom, Inc. (DXCM) Will Post Quarterly Sales of $211.91 Million
www.americanbankingnews.com - November 25 at 8:20 AM
Lilly Inks Deal to Include Dexcom Products in Diabetes SystemLilly Inks Deal to Include Dexcom Products in Diabetes System
finance.yahoo.com - November 22 at 6:49 PM
DexCom (DXCM) Reports Development Agreement with Eli Lily (LLY) for Dexcom CGM Integration Into Connected ... - StreetInsider.comDexCom (DXCM) Reports Development Agreement with Eli Lily (LLY) for Dexcom CGM Integration Into Connected ... - StreetInsider.com
www.streetinsider.com - November 22 at 4:34 AM
Insider Selling: DexCom, Inc. (DXCM) CEO Sells 12,000 Shares of StockInsider Selling: DexCom, Inc. (DXCM) CEO Sells 12,000 Shares of Stock
www.americanbankingnews.com - November 21 at 8:21 PM
Barbara Kahn Sells 3,000 Shares of DexCom, Inc. (DXCM) StockBarbara Kahn Sells 3,000 Shares of DexCom, Inc. (DXCM) Stock
www.americanbankingnews.com - November 20 at 10:54 PM
DexCom, Inc. breached its 50 day moving average in a Bullish Manner : DXCM-US : November 20, 2017DexCom, Inc. breached its 50 day moving average in a Bullish Manner : DXCM-US : November 20, 2017
finance.yahoo.com - November 20 at 6:57 PM
Reviewing DexCom (DXCM) and Its RivalsReviewing DexCom (DXCM) and Its Rivals
www.americanbankingnews.com - November 18 at 5:20 PM
Dexcom CEO doesn't think patients will drop his company's...Dexcom CEO doesn't think patients will drop his company's...
finance.yahoo.com - November 17 at 12:50 PM
Dexcom CEO: We don't think patients will drop our feature...Dexcom CEO: We don't think patients will drop our feature...
finance.yahoo.com - November 17 at 12:50 PM
ETFs with exposure to DexCom, Inc. : November 17, 2017ETFs with exposure to DexCom, Inc. : November 17, 2017
finance.yahoo.com - November 17 at 12:50 PM
Comparing DexCom (DXCM) & The CompetitionComparing DexCom (DXCM) & The Competition
www.americanbankingnews.com - November 12 at 3:10 AM
DexCom, Inc. (DXCM) Director Steven R. Altman Purchases 10,000 SharesDexCom, Inc. (DXCM) Director Steven R. Altman Purchases 10,000 Shares
www.americanbankingnews.com - November 8 at 9:22 PM
ETFs with exposure to DexCom, Inc. : November 6, 2017ETFs with exposure to DexCom, Inc. : November 6, 2017
finance.yahoo.com - November 6 at 7:31 PM
Q4 2017 Earnings Forecast for DexCom, Inc. (DXCM) Issued By William BlairQ4 2017 Earnings Forecast for DexCom, Inc. (DXCM) Issued By William Blair
www.americanbankingnews.com - November 6 at 9:00 AM
FY2017 EPS Estimates for DexCom, Inc. (DXCM) Raised by Oppenheimer HoldingsFY2017 EPS Estimates for DexCom, Inc. (DXCM) Raised by Oppenheimer Holdings
www.americanbankingnews.com - November 6 at 6:14 AM
FY2017 Earnings Forecast for DexCom, Inc. Issued By Wedbush (DXCM)FY2017 Earnings Forecast for DexCom, Inc. Issued By Wedbush (DXCM)
www.americanbankingnews.com - November 6 at 6:14 AM
FY2017 EPS Estimates for DexCom, Inc. Increased by Analyst (DXCM)FY2017 EPS Estimates for DexCom, Inc. Increased by Analyst (DXCM)
www.americanbankingnews.com - November 6 at 6:14 AM
Research Analysts Offer Predictions for DexCom, Inc.s FY2017 Earnings (DXCM)Research Analysts Offer Predictions for DexCom, Inc.'s FY2017 Earnings (DXCM)
www.americanbankingnews.com - November 6 at 6:14 AM
DexCom, Inc. (DXCM) Expected to Earn FY2017 Earnings of ($0.62) Per ShareDexCom, Inc. (DXCM) Expected to Earn FY2017 Earnings of ($0.62) Per Share
www.americanbankingnews.com - November 6 at 6:14 AM
DexCom, Inc. (DXCM) Expected to Announce Quarterly Sales of $220.67 MillionDexCom, Inc. (DXCM) Expected to Announce Quarterly Sales of $220.67 Million
www.americanbankingnews.com - November 6 at 4:56 AM
VWR Corporation (VWR) & DexCom (DXCM) Head-To-Head SurveyVWR Corporation (VWR) & DexCom (DXCM) Head-To-Head Survey
www.americanbankingnews.com - November 6 at 3:26 AM
DexCom, Inc. (DXCM) PT Lowered to $52.00 at Morgan StanleyDexCom, Inc. (DXCM) PT Lowered to $52.00 at Morgan Stanley
www.americanbankingnews.com - November 5 at 10:18 AM
$0.02 EPS Expected for DexCom, Inc. (DXCM) This Quarter$0.02 EPS Expected for DexCom, Inc. (DXCM) This Quarter
www.americanbankingnews.com - November 4 at 5:10 AM
DexCom Launches “Call of the Warrior” Campaign for National Diabetes Awareness MonthDexCom Launches “Call of the Warrior” Campaign for National Diabetes Awareness Month
finance.yahoo.com - November 4 at 4:34 AM
U.S. Diabetes Patients Are About to Get Some High-Tech ReliefU.S. Diabetes Patients Are About to Get Some High-Tech Relief
finance.yahoo.com - November 4 at 4:34 AM
DexCom, Inc. :DXCM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017DexCom, Inc. :DXCM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017
finance.yahoo.com - November 3 at 1:28 PM
DexCom (DXCM) Q3 Loss Narrower Than Expected, Revenues Meet - NasdaqDexCom (DXCM) Q3 Loss Narrower Than Expected, Revenues Meet - Nasdaq
www.nasdaq.com - November 2 at 7:09 PM
DexCom, Inc. (DXCM) Receives Hold Rating from Northland SecuritiesDexCom, Inc. (DXCM) Receives Hold Rating from Northland Securities
www.americanbankingnews.com - November 2 at 1:16 PM
DexCom, Inc. Reports Record Third Quarter 2017 Financial Results - Business Wire (press release)DexCom, Inc. Reports Record Third Quarter 2017 Financial Results - Business Wire (press release)
www.businesswire.com - November 2 at 5:04 AM
Edited Transcript of DXCM earnings conference call or presentation 1-Nov-17 8:30pm GMTEdited Transcript of DXCM earnings conference call or presentation 1-Nov-17 8:30pm GMT
finance.yahoo.com - November 2 at 5:04 AM
DexCom (DXCM) Q3 2017 Results - Earnings Call TranscriptDexCom (DXCM) Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 2 at 12:03 AM
DexCom, Inc. to Host Earnings CallDexCom, Inc. to Host Earnings Call
finance.yahoo.com - November 1 at 7:01 PM
DexCom, Inc. Reports Record Third Quarter 2017 Financial ResultsDexCom, Inc. Reports Record Third Quarter 2017 Financial Results
finance.yahoo.com - November 1 at 7:01 PM
DexCom reports 3Q lossDexCom reports 3Q loss
finance.yahoo.com - November 1 at 7:01 PM
DexCom, Inc. (DXCM) Receives Consensus Rating of "Buy" from AnalystsDexCom, Inc. (DXCM) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - November 1 at 5:48 AM
DexCom (DXCM) versus Cytori Therapeutics (CYTX) Critical ReviewDexCom (DXCM) versus Cytori Therapeutics (CYTX) Critical Review
www.americanbankingnews.com - October 31 at 1:14 AM
DexCom, Inc. (DXCM) Lowered to "D+" at TheStreetDexCom, Inc. (DXCM) Lowered to "D+" at TheStreet
www.americanbankingnews.com - October 28 at 10:52 PM
ETFs with exposure to DexCom, Inc. : October 27, 2017ETFs with exposure to DexCom, Inc. : October 27, 2017
finance.yahoo.com - October 28 at 2:17 AM
Head-To-Head Comparison: DexCom (DXCM) and Its RivalsHead-To-Head Comparison: DexCom (DXCM) and Its Rivals
www.americanbankingnews.com - October 26 at 1:38 PM
Richard Doubleday Sells 1,635 Shares of DexCom, Inc. (DXCM) StockRichard Doubleday Sells 1,635 Shares of DexCom, Inc. (DXCM) Stock
www.americanbankingnews.com - October 25 at 8:46 PM
DexCom, Inc. to Post FY2018 Earnings of ($0.38) Per Share, Jefferies Group Forecasts (DXCM)DexCom, Inc. to Post FY2018 Earnings of ($0.38) Per Share, Jefferies Group Forecasts (DXCM)
www.americanbankingnews.com - October 25 at 6:04 PM

SEC Filings

DexCom (NASDAQ:DXCM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

DexCom (NASDAQ:DXCM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

DexCom (NASDAQ DXCM) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.